1786 — Scivision Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Scivision Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	428	413	696	674	804
Net Total Accounts Receivable
Net Total Receivables	61.3	68.2	78.9	91.5	96.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	547	553	925	881	1,004
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,266	1,296	1,246	1,184	1,135
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,862	1,891	2,262	2,098	2,160
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	150	122	426	128	145
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	501	487	812	587	534
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,361	1,404	1,450	1,511	1,627
Total Liabilities & Shareholders' Equity	1,862	1,891	2,262	2,098	2,160
Total Common Shares Outstanding